Tuesday, December 30, 2025 | 10:59 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Glenmark Pharmaceuticals gets ANDA approval for two oral contraceptives

Image

Capital Market

From USFDA

Glenmark Pharmaceuticals has been granted final approval by United States Food & Drug Administration for Drospirenone and Ethinyl Estradiol Tablets USP, 3mg/ 0.03 mg, the generic version of Yasmin Tablets of Bayer Healthcare Pharmaceuticals Inc. (Bayer) and for Levonorgestrel Tablets, 1.5 mg, the generic version of Plan B One-Step Tablet of Teva Branded Pharmaceutical Product R&D Inc., for over the counter use.

Powered by Capital Market - Live News

 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 28 2016 | 9:10 AM IST

Explore News